Fentanyl Citrate Solubility UK Tips From The Top In The Business

Understanding the Solubility of Fentanyl Citrate: A Technical Overview for UK Pharmaceutical Contexts

Disclaimer: This article is planned for educational and professional information purposes only. Fentanyl citrate is a Class An illegal drug in the United Kingdom under the Misuse of Drugs Act 1971. Handling and formulation should only be conducted by certified experts in controlled environments.

In the world of pharmacology and scientific medication, fentanyl citrate remains one of the most potent synthetic opioids readily available. Due to its high effectiveness and quick onset of action, it is a foundation of pain management and anaesthesia in the UK's National Health Service (NHS) and personal health care sectors. However, the pharmacological efficiency of any drug is fundamentally connected to its physicochemical properties-- particularly its solubility.

Understanding the solubility of fentanyl citrate is essential for pharmacists, researchers, and clinicians to ensure stable formulas, precise dosing, and efficient drug shipment across different administration routes.


What is Fentanyl Citrate?

Fentanyl citrate is the citrate salt of fentanyl, a phenylpiperidine derivative. While fentanyl base is extremely lipophilic (fat-soluble), it has limited solubility in aqueous environments. By reacting the base with citric acid, moving into the salt form (fentanyl citrate), the solubility in water is considerably enhanced. This makes it ideal for intravenous (IV), intramuscular (IM), and transdermal applications.

In the UK, fentanyl citrate is manufactured according to the requirements set by the British Pharmacopoeia (BP). It typically looks like a white, crystalline powder or as granules that are odorless.

Secret Physicochemical Properties

Residential or commercial property

Value/Description

Chemical Formula

₤ C _ 22 H _ 28 N _ 2 O \ cdot C _ 6 H _ 8 O _ 7 ₤

Molecular Weight

528.6 g/mol

CAS Number

990-73-8

pKa

Roughly 8.4 (at 25 ° C

)Appearance White crystalline powder Octanol-Water Partition Coefficient(Log P)~ 4.05(base

)Solubility Profile in Various Solvents The solubility of fentanyl citrate differs considerably depending


on the solvent used and the ambient temperature. In

a pharmaceutical setting, water is the primary solvent of interest for injectables, but natural solvents are frequently used throughout the manufacturing of transdermal spots or nasal sprays. Aqueous Solubility In the UK medical context, fentanyl citrate is most commonly experienced as a 50 mcg/mL option for injection. At space temperature(around 20 ° C to 25 ° C), fentanyl

citrate is considered"moderately soluble"in water. Scientific literature normally suggests a solubility limit of approximately 25 mg/mL in water at 25 ° C, which is more than enough for standard scientific concentrations. Organic Solvent Solubility Fentanyl citrate shows diverse solubility in organic solvents, which is critical for creating non-aqueous drug delivery systems. Table 1: Solubility

of Fentanyl Citrate in Common Solvents at 25 ° C Solvent Solubility Category(approx.)Quantitative Estimate Water Moderately Soluble ~ 25 mg/mL Methanol Freely Soluble > 100 mg/mL Ethanol(95 %) Soluble ~ 10-- 30 mg/mL Chloroform Soluble ~ 20-- 30 mg/mL Isopropyl Alcohol A little Soluble

<10 mg/mL Factors Influencing Solubility and Stability The solubility of fentanyl citrate is not a static worth; it

is affected by several environmental and chemical factors that need to be managed throughout intensifying and

storage.

1. The Impact of pH As the

>citrate salt of a

weak base, the solubility of fentanyl is highly pH-dependent. Acidic Environments: Fentanyl citrate remains highly soluble in acidic to neutral solutions. Most UK-licensed fentanyl injections are buffered to a pH range of

4.0 to 7.5. Alkaline Environments: If the pH of an option rises significantly above 7.5, there is a danger that the fentanyl


will shift back into its base type. Since the base

form is considerably less soluble in water, this can lead to"crashing out"or rainfall, which is exceptionally unsafe in an IV setting. 2. Temperature level Effects Like many crystalline solids, the solubility of fentanyl citrate increases with temperature level. While this is valuable during the industrial dissolution procedure, it poses a threat throughout storage . If a saturated solution is prepared at a heat and then cooled (such as during transportation in cold UK winter seasons), the solute may take shape. 3. Existence of Other Ions(Common **Ion Effect )The presence of other citrate salts in the solution can reduce the solubility of fentanyl citrate due to the common ion effect. This is a necessary consideration when mixing fentanyl with other medications in a syringe or infusion bag. 4. Buffer Capacity The option of buffer(e.g., sodium citrate or phosphate buffers)is

vital in maintaining a steady environment where the drug stays in its ionized, soluble kind. Developing for the UK Market: British Pharmacopoeia Standards In the United Kingdom, medicinal items need to follow the British Pharmacopoeia(BP). The BP provides particular essays for Fentanyl Citrate, making sure purity, effectiveness, and solubility standards are satisfied. Secret Compounding and Formulation Rules: Clarity of Solution: The BP needs that parenteral options be clear and devoid of noticeable particles. This is achieved by guaranteeing the concentration remains well below the saturation point. Sterility: Given the aqueous nature of the solution, formulas need to be

### sanitized, typically

by means of autoclaving or filtration, which can affect the stability if the solubility limits are tight. Excipients: Common ingredients in UK fentanyl solutions consist of Sodium Chloride( for isotonicity

)and Sodium Hydroxide or Hydrochloric Acid (for pH change). Practical Applications of Solubility Knowledge Why does a deep understanding of fentanyl citrate's solubility matter to the health care expert? Avoiding Precipitation: Knowing that fentanyl is incompatible with extremely alkaline

**options(like thiopentone or some bicarbonate services

*   **)prevents the development of precipitates that could trigger embolic events. Optimizing Drug Delivery: In the advancement of sublingual or buccal tablets (e.g., Abstral or Effentora used in the UK), the drug should dissolve*   **rapidly in the small volume of saliva offered. Transdermal Flux: While patches rely on the lipophilicity of the fentanyl base, the manufacture of these spots often includes dissolving the citrate salt in an unstable solvent*   **before it is impregnated into the adhesive matrix. Storage and Handling Recommendations To maintain the solubility and effectiveness of fentanyl citrate items, the following guidelines are normally

            * * *

            followed in British scientific settings: Temperature
            ----------------------------------------------------

            Control: Store at controlled room temperature (15 ° C to 25 ° C). Prevent freezing, as this can lead to irreversible precipitation in**certain formulas. Light** Protection: Fentanyl citrate is somewhat light-sensitive. [Medic Store GB](https://medicstoregb.uk/buy-fentanyl/) need to be kept in amber glass or nontransparent packaging. Dealing with Potency: Because of its high solubility and strength, unexpected skin contact*   **with concentrated options** can lead to systemic absorption. Expert PPE is compulsory. Regularly Asked Questions(FAQ)Is fentanyl citrate more soluble than fentanyl base? Yes, substantially.
            *   **The citrate salt is created specifically to increase liquid solubility, making it suitable for injections. The base type is extremely lipophilic and is usually utilized in the internal layers of transdermal patches. Does the UK BP(British Pharmacopoeia)vary

                from the USP regarding solubility? The basic

                solubility profiles equal as they describe the exact same chemical entity. Nevertheless, the specific screening methods and the prioritized solvents for pureness testing may vary

                *   **slightly between the BP** and the United States Pharmacopeia (USP). Can I blend fentanyl citrate with saline? Yes. Fentanyl citrate is compatible with 0.9%Sodium Chloride(Normal**Saline )and 5%Dextrose. These are standard diluents used in UK medical facilities. What occurs if a fentanyl solution becomes cloudy? If a solution of fentanyl citrate appears cloudy or includes** crystals, it must be disposed of. This suggests that the drug has precipitated out of the solution, either due to pH changes, temperature level shifts, or contamination.

                * * *

                Why is citric acid utilized specifically?
                -----------------------------------------

                ### Citric acid is a well-tolerated, pharmaceutical-grade natural acid. It forms a stable salt with fentanyl that offers a balance of high water solubility and compatible pH for human tissue. Fentanyl citrate is an important pharmacological tool in the UK, however its security and effectiveness are predicated on

                ### its chemical stability. Solubility is possibly the most important aspect in this regard

                . By keeping an ideal pH, picking the right solvents, and adhering to British Pharmacopoeia standards, the pharmaceutical market makes sure that this powerful analgesic stays a trusted choice for patient care.

                ### For clinicians, the takeaway is easy: always verify compatibility before blending and make sure storage conditions are strictly satisfied to avoid the drug from losing its soluble state.  
                ![](https://medicstoregb.uk/wp-content/uploads/2025/09/cropped-WhatsApp-Image-2025-11-22-at-2.39.06-AM.jpeg.webp)







                -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

                **

            ******

**


------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

****


Edit

Pub: 12 May 2026 09:21 UTC

Views: 1